Content
12/16/2024
New York, NY USA
Precision Neuroscience
completed $102 million Series C Round funding. Investors include
General Equity Holdings (lead), B Capital, Steadview Capital.
About
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from neurological illnesses. We are building the only brain–computer interface that is designed to be minimally invasive, safely removable, and capable of processing large amounts of data.
Startup
Sector:
Tech
Life Science
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
